In GLP-1, attack surfaces shift as entrants adopt alternative long-acting chemistries and delivery systems
Cells 2020;9:118
And in a recent survey of state Medicaid directors conducted by KFF, a health policy research organization, they said cost and potential side effects are among their concerns
Both formulations are manufactured to identical research-grade standards, both come with independent third-party testing, and both ship under the same Canadian-domestic supply framework
El mercado global de los GLP-1 ha superado ya los 100 mil millones de dlares, con proyecciones que estiman una expansin cercana a los 300 mil millones hacia 2030, impulsada principalmente por compaas como Novo Nordisk y Eli Lilly
Ethics declarations Conflict of Interest Diego Maria Michele Fornasari received fees as congress speaker or consultant from the following pharmaceutical companies: Angelini, Abiogen, Alfasigma (the manufacturer of acetyl-l-carnitine), Chiesi, Istituto Gentili, Grunentahl, Molteni, Sandoz, SPA, Viatris, Zambon